Replies to post #289670 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

from his assertion this

20,000 ndGBM per year in US x $100,000 per patient = $2 billion revenue x 10x multiple = $20 billion market cap

is absolutely ridiculous

A. NWBO will never cater ALL GBM patients perhaps 25%
B. x10 is outrages most BIO go at x5 x6 revenue max
C. even if DCVAXL is approved it will take many years before NWBO (if its not acquired) gets to that number in sales